12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Company News  |  Deals

Illumina, Roche deal

Roche extended the deadline for its unsolicited tender offer for Illumina to March 23 from Feb. 24. Roche is offering $44.50 per share,...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >